Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Enterade is a proprietary, glucose-free, amino acid-based medical food designed to alleviate gastrointestinal toxicity associated with cancer therapies, including chemotherapy and radiation. Developed by Entrinsic Bioscience, it contains a specific mixture of amino acids—aspartic acid, valine, serine, threonine, and tyrosine—along with electrolytes. The product functions as an oral rehydration solution that supports the intestinal mucosal barrier, promotes crypt cell proliferation, and enhances the absorption of fluids and nutrients. It is primarily used to manage symptoms such as diarrhea, nausea, dehydration, and weight loss in oncology patients and those with neuroendocrine tumors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Enterade.